What are the signs and symptoms of cholestasis of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Intrahepatic Cholestasis of Pregnancy

Intrahepatic cholestasis of pregnancy (ICP) is characterized primarily by pruritus (itching) without a primary rash, typically occurring in the second and third trimesters, accompanied by elevated serum bile acid levels. 1, 2

Primary Clinical Presentation

  • Pruritus characteristics:

    • Generalized itching, but predominantly affects the palms and soles of the feet 1, 2
    • Typically worse at night 1, 2
    • No primary rash (distinguishing feature from other pruritic conditions of pregnancy) 1
    • May develop excoriations or prurigo nodularis from intense scratching, which can be mistaken for a primary rash 1
  • Timing:

    • Occurs in the second and third trimesters of pregnancy 1, 2
    • Most commonly presents in the third trimester 3
  • Laboratory abnormalities:

    • Elevated serum bile acid levels (≥10 μmol/L) - the most sensitive indicator 1, 2
    • Elevated liver enzymes (ALT, AST) in most cases 1
    • Bile acid elevation may precede other liver test abnormalities 1
    • Mild jaundice with moderately elevated conjugated bilirubin occurs in only 10-15% of cases 1

Notable Absent Features

  • No primary rash (key distinguishing feature from other pruritic dermatoses of pregnancy) 1, 2
  • Excessive fatigue, insomnia, malaise, and abdominal pain/colic are not common with ICP 1
  • Liver failure does not occur 4

Risk Factors and Epidemiology

  • More common in multiple pregnancies (twins) due to higher hormonal levels 1, 2
  • Incidence ranges from 0.3% to 15% in various populations, with most estimates between 0.3% and 0.5% 1
  • Higher incidence in family members suggests genetic factors 1
  • Early-onset ICP (before 33 weeks) may be associated with increased fetal complications 1, 2

Disease Course

  • Symptoms spontaneously resolve within 4-6 weeks after delivery 1, 2
  • Persistence of abnormalities after delivery should prompt investigation for other chronic liver diseases like PBC, PSC, ABCB4 deficiency, or chronic hepatitis C 1

Clinical Significance

  • While ICP poses little risk to pregnant women, it confers significant risk to the fetus 1
  • Associated with increased risk of:
    • Preterm delivery
    • Meconium-stained amniotic fluid
    • Fetal distress
    • Stillbirth 1, 5, 3
  • Risk of adverse fetal outcomes increases with bile acid levels >40 μmol/L 2
  • Significantly increased risk of stillbirth after 35 weeks gestation with bile acid levels >100 μmol/L 2

Diagnostic Approach

When evaluating a pregnant woman with pruritus, clinicians should:

  1. Confirm absence of primary rash (may have secondary excoriations)
  2. Measure serum bile acid levels (diagnostic if ≥10 μmol/L with pruritus)
  3. Perform liver function tests (ALT, AST, bilirubin)
  4. Consider other causes of pruritus without rash if laboratory findings are normal 1, 2

The diagnosis of ICP should be considered in any pregnant woman who develops new-onset pruritus without a rash in the second half of pregnancy, particularly when it affects the palms and soles and is worse at night.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Intrahepatic Cholestasis of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intrahepatic cholestasis of pregnancy.

Obstetrics and gynecology, 2014

Research

Cholestasis of pregnancy.

Journal of gastroenterology and hepatology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.